38.26
price up icon1.73%   0.65
after-market After Hours: 37.40 -0.86 -2.25%
loading
Apogee Therapeutics Inc stock is traded at $38.26, with a volume of 567.62K. It is up +1.73% in the last 24 hours and down -11.90% over the past month. Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
See More
Previous Close:
$37.61
Open:
$37.3
24h Volume:
567.62K
Relative Volume:
0.65
Market Cap:
$1.76B
Revenue:
-
Net Income/Loss:
$-146.66M
P/E Ratio:
-13.89
EPS:
-2.7541
Net Cash Flow:
$-133.21M
1W Performance:
-8.12%
1M Performance:
-11.90%
6M Performance:
-7.50%
1Y Performance:
-21.44%
1-Day Range:
Value
$37.29
$38.54
1-Week Range:
Value
$36.82
$41.55
52-Week Range:
Value
$26.20
$63.50

Apogee Therapeutics Inc Stock (APGE) Company Profile

Name
Name
Apogee Therapeutics Inc
Name
Phone
650-394-5230
Name
Address
221 CRESCENT ST., WALTHAM
Name
Employee
196
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
APGE's Discussions on Twitter

Compare APGE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
APGE
Apogee Therapeutics Inc
38.26 2.19B 0 -146.66M -133.21M -2.7541
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-07-25 Reiterated BTIG Research Buy
Mar-13-25 Initiated Citigroup Buy
Nov-25-24 Initiated Canaccord Genuity Buy
May-10-24 Initiated BofA Securities Buy
Dec-20-23 Initiated BTIG Research Buy
Aug-08-23 Initiated Guggenheim Buy
Aug-08-23 Initiated Jefferies Buy
Aug-08-23 Initiated Stifel Buy
Aug-08-23 Initiated TD Cowen Outperform
Aug-08-23 Initiated Wedbush Outperform
View All

Apogee Therapeutics Inc Stock (APGE) Latest News

pulisher
Jul 31, 2025

Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug - Insider Monkey

Jul 31, 2025
pulisher
Jul 30, 2025

11 Best Future Stocks to Buy Now - Insider Monkey

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 23:15:33 - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma - MSN

Jul 30, 2025
pulisher
Jul 29, 2025

Earnings visualization tools for Apogee Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Multi Factor Analysis Ranks Apogee Therapeutics Inc. as Strong BuyIntraday Trend Analysis for Fast Gains Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Order Book Volume Tilts Bullish on Apogee Therapeutics Inc.Trade Ready Stock Watch for Short Term Published - metal.it

Jul 29, 2025
pulisher
Jul 27, 2025

Should I hold or sell Apogee Therapeutics Inc. stock in 2025Triple-digit growth rates - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Apogee Therapeutics Inc. stock overvalued or undervaluedFind the best stocks for sustainable growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Apogee Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Intrinsic Value of Apogee Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Elite Traders Group - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Apogee Therapeutics Inc. stockOver 200% growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Apogee Therapeutics Inc. stock priceDynamic growth stocks - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Apogee Therapeutics Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

What makes Apogee Therapeutics Inc. stock attractive to long term investorsDynamic growth stocks - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 22, 2025

Is Apogee Therapeutics Inc. a good long term investmentOutstanding capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 20, 2025

Teacher Retirement System of Texas Sells 629 Shares of Apogee Therapeutics Inc. (NASDAQ:APGE) - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Will Apogee Therapeutics Inc. stock benefit from interest rate changesTop Gaining Low Risk Assets - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey

Jul 17, 2025
pulisher
Jul 15, 2025

Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Why Apogee Therapeutics Inc. stock attracts strong analyst attentionLow Risk Stock Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Apogee Therapeutics Inc. stock performs during market volatilityStable Growth Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Canaccord Genuity Reiterated a Buy Rating on Apogee Therapeutics (APGE) - Insider Monkey

Jul 14, 2025
pulisher
Jul 14, 2025

Analysts Set Apogee Therapeutics Inc. (NASDAQ:APGE) Price Target at $99.00 - Defense World

Jul 14, 2025

Apogee Therapeutics Inc Stock (APGE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
Cap:     |  Volume (24h):